Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Sage Therapeutics
Biotech
Sage fails first of 4 tests for key prospect, exits Parkinson's
Sage Therapeutics has set a bad PRECEDENT for dalzanemdor with a phase 2 failure in Parkinson's disease.
Nick Paul Taylor
Apr 17, 2024 8:34am
Sanofi finds new R&D head—Chutes & Ladders
Sep 1, 2023 9:30am
Sage lays off 40%, shakes up C-suite to get zuranolone to market
Aug 31, 2023 7:44am
Sage braces for layoffs after FDA rejects zuranolone for MDD
Aug 7, 2023 9:54am
Biogen's tight-lipped zuranolone remarks disquiet Sage investors
Jul 26, 2023 10:45am
Amgen poaches Moderna CMO—Chutes & Ladders
Jun 16, 2023 9:30am